Witryna10 kwi 2024 · IMMUNOGEN, INC. (IMGN) Add to my list. Report. Delayed Nasdaq - 04:00:00 2024-04-10 pm EDT 3.860: USD -5.39%: 03:32a: BioPharma Credit to Invest $63 Million in ImmunoGen: MT. 03:18a: BioPharma Credit, BioPharma V agree USD125 million loan for ImmunoGen: AN. 04/06: ImmunoGen Secures Up to $175 Million in … Witryna31 mar 2024 · March 31, 2024. For the readers interested in the stock health of ImmunoGen Inc. (IMGN). It is currently valued at $3.71. When the transactions were called off in the previous session, Stock hit the highs of $3.84, after setting-off with the price of $3.84. Company’s stock value dipped to $3.66 during the trading on the day.
ImmunoGen Inc - Company Profile and News - Bloomberg Markets
WitrynaCompany profile page for ImmunoGen Inc including stock price, company news, press releases, executives, board members, and contact information czech embassy in iran
IMGN Stock Forecast, Price & News (ImmunoGen) - MarketBeat
Witryna10 kwi 2024 · ImmunoGen Inc. (NASDAQ:IMGN)’s beta value is currently sitting at 0.93, while the Average True Range indicator is currently displaying 0.21. With analysts … Witryna11 kwi 2024 · About IMGN. ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant … WitrynaIMGN - key executives, insider trading, ownership, revenue and average growth rates. Detailed company description & address for Immunogen Inc.. czech embassy in lebanon